Assenagon Asset Management S.A. 13D and 13G filings for Catalyst Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-01-18 06:15 am Sale | 2022-01-14 | 13G | Catalyst Biosciences, Inc. CBIO | Assenagon Asset Management S.A. | 0 0.000% | -475,856 (Position Closed) | Filing |
| 2022-01-18 06:12 am Purchase | 2022-01-13 | 13G | Catalyst Biosciences, Inc. CBIO | Assenagon Asset Management S.A. | 475,856 5.980% | 193,267 (+68.39%) | Filing |
| 2020-08-06 11:13 am Purchase | 2020-06-17 | 13G | Catalyst Biosciences, Inc. CBIO | Assenagon Asset Management S.A. | 282,589 6.390% | 222,819 (+372.79%) | Filing |
| 2020-08-06 11:13 am Purchase | 2020-06-18 | 13G | Catalyst Biosciences, Inc. CBIO | Assenagon Asset Management S.A. | 59,771 1.070% | 59,771 (New Position) | Filing |
| 2020-06-19 10:20 am Sale | 2020-06-18 | 13G | Catalyst Biosciences, Inc. CBIO | Assenagon Asset Management S.A. | 59,771 1.070% | -222,819 (-78.85%) | Filing |
| 2020-06-19 10:18 am Purchase | 2020-06-17 | 13G | Catalyst Biosciences, Inc. CBIO | Assenagon Asset Management S.A. | 282,589 6.390% | 282,589 (New Position) | Filing |